Enoxaparin for VTE thromboprophylaxis during inpatient rehabilitation care: assessment of the standard fixed dosing regimen.
Journal Information
Full Title: BMC Pharmacol Toxicol
Abbreviation: BMC Pharmacol Toxicol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThis study was an observational, prospective cohort study approved by the Institutional Ethics Committee on Human Research at the Loewenstein Rehabilitation Medical Center (No. NCT103593291). Informed consent was obtained from all individual participants included in the study and all methods were performed in accordance with relevant guidelines in the Declaration of Helsinki. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."
"Funding The authors did not receive support from any organization for the submitted work."
"Trial registration No. NCT103593291, registered August 2018."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025